title: [Selective serotonine reuptake inhibitors (SSRI) in the treatment of paraphilia].
abstract: For about 15 years selective serotonine reuptake inhibitors (SSRI) have been used in the treatment of paraphilias. In an open, uncontrolled, retrospective study, which was the first in the German speaking countries we investigated 16 male outpatients, who have been treated for different paraphilias with SSRI and psychotherapy. There was a marked reduction in paraphilic symptoms. Despite high rates of sexual side effects most patients reported a high overall treatment satisfaction. SSRI are an important addition in pharmacological treatment of paraphilic patients, especially with a risk of so called "hands-off" delinquency.
authors.affiliation: Institut für Sexualforschung und Forensische Psychiatrie, Psychiatrie und Psychotherapie der Universität Hamburg, Hamburg. kraus@uke.uni-hamburg.de
authors.forename: C
authors.initials: C
authors.lastname: Kraus
authors.forename: K
authors.initials: K
authors.lastname: Strohm
authors.forename: A
authors.initials: A
authors.lastname: Hill
authors.forename: N
authors.initials: N
authors.lastname: Habermann
authors.forename: W
authors.initials: W
authors.lastname: Berner
authors.forename: P
authors.initials: P
authors.lastname: Briken
mesh_terms: D000328:Adult; D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D010262:Paraphilic Disorders / Q000188:drug therapy* / Q000523:psychology; D012189:Retrospective Studies; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D012959:Socioeconomic Factors; D016896:Treatment Outcome
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors